The New York Times has reversed years of pro-legalization stance with an editorial titled “It’s Time for America to Admit That It Has a Marijuana Problem,” arguing that legalization has brought real and growing harms and urging tighter federal and state controls. Experts and surveys now point to sharp increases in daily use, rising potency, addiction risks, psychosis cases, and new medical complaints that regulators ignored while the industry expanded. This piece looks at the change of heart, the evidence driving it, and the policy options being proposed to bring order to a messy market. Expect a clear push for stronger rules, higher taxes on concentrated products, and stricter limits on outrageous medical claims.
The Times’ reversal is striking because it once argued a federal ban should be repealed and decisions should be left to states. “Prohibition has proved to be a costly failure, with harsh consequences for millions of Americans,” the 2014 piece stated, but the newer editorial says legalization has created its own set of problems. That shift forced a close look at usage data and the health impacts now surfacing.
Survey data are a wake-up call for anyone who treated legalization as harmless. A 2024 survey from Carnegie Mellon found that approximately 18 million Americans used marijuana daily or near-daily — a “a deeply disturbing number,” according to Dr. Marc Siegel. By contrast, 14.7 million people are daily or near-daily drinkers, and daily cannabis use rose roughly 15-fold from 1992 to 2022.
Researchers point to product changes and consumer habits as key drivers of the surge. “Greater use of ‘new’ product forms — meaning vapes, dabs and edibles, versus joints and bongs — are fairly longstanding, and I would guess that more likely than not, they probably have continued,” Jonathan Caulkins said, noting how concentrates and edibles changed the landscape. “For example, edibles are prone to people inadvertently taking more than desired because there is a delay before the effects hit,” he added.
Inhaling any kind of smoke carries obvious risks, and cannabis is no exception. “That is riskier to inhale into the lungs — a fragile and sensitive organ — than the stomach, which is well-equipped to deal with contaminants,” Caulkins said, pointing out the different health profiles of product types. Those differences matter when ultra-potent concentrates and frequent daily use become common.
Dependence and addiction are showing up in the data, with public health agencies warning of increased risk. Frequent cannabis users are much more likely to become dependent, with at least one in 10 developing an addiction, according to the U.S. Substance Abuse and Mental Health Services Administration. “Cannabis is definitely addictive — the brain is affected, leading directly to addiction,” Siegel said. “It also interferes with performance and memory.”
Clinicians are seeing severe cases linked to high-potency cannabis, especially among vulnerable young people. “As a psychiatrist specializing in the treatment of psychotic and mood disorders, I have witnessed the devastating impact that heavy use of high-potency cannabis can have on a subset of vulnerable young adults who develop severe and persistent psychotic disorders,” Dr. Laura Gardner said. “When I treat young adults in the hospital whose lives have been completely derailed by the onset of severe psychosis associated with cannabis use, the typical response I get is outrage — ‘How did we not know about this? Why did no one warn us that this could happen?’”
Other clinical problems are rising too, including cannabinoid hyperemesis syndrome, which brings repeated bouts of severe nausea and vomiting. Studies show this condition affects nearly 2.8 million Americans each year, a burden that adds strain to emergency rooms and families. Experts argue many of these harms were underestimated when policymakers embraced hands-off legalization.
The editorial stopped short of calling for a return to mass criminalization, but it did call for far tougher regulation. “The unfortunate truth is that the loosening of marijuana policies — especially the decision to legalize pot without adequately regulating it — has led to worse outcomes than many Americans expected,” the Times editorial said. “America should not go back to prohibition to fix these problems,” it wrote. “There is a lot of space between heavy-handed criminal prohibition and hands-off commercial legalization.”
Practical remedies on the table include higher taxes and product limits aimed at concentrates. “Today’s cannabis is far more potent than the pot that preceded legalization,” the Times said. “The appropriate response is both to make illegal any marijuana product that exceeds a THC level of 60% and to impose higher taxes on potent forms of pot,” the board recommended, while also urging enforcement against false medical claims. “The government should crack down on these outlandish claims.”
Even some industry and policy analysts admit the system needs course correction and that taxes could fund education and treatment. “One aspect of cannabis legalization that is left out of the article is that the industry already pays significant taxes,” Riana Durrett said. “Anybody who believes cannabis legalization has been detrimental needs to focus their attention on dedicating the tax revenue toward public health efforts and campaigns.” “Ending legalization will not work — but using the tax dollars to educate the public on the realities of cannabis consumption can clear up misconceptions about health impacts.”
